Menu
Recruiting NCT06904768

Effect of Shoulder Sling Use on Balance and Mobility in Subacute Stroke Patients

No phase Interventional Hemiplegia Balance Disorders Mobility Limitation Shoulder Subluxation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Shoulder Sling, No Sling.
Who it may be relevant to
Registry conditions: Hemiplegia, Balance Disorders, Mobility Limitation, Shoulder Subluxation. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Greece
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Cross-Over Study on the Effect of Shoulder Sling Use on Balance and Functional Mobility in Patients With Hemiplegia During the Subacute Phase of Stroke Rehabilitation

Overview

This study examines whether wearing a shoulder sling can improve balance and mobility in people who are recovering from a stroke. Participants will perform simple movement and balance tests twice-once with the sling and once without. The goal is to find out if using the sling helps patients feel more stable and safe during walking and everyday activities.

Detailed description

This is a cross-over study designed to evaluate the impact of shoulder sling use on balance and functional mobility in patients recovering from stroke in the subacute phase. Participants will be asked to complete three validated functional tests: the Timed Up and Go (TUG) test, the Functional Reach Test (FRT), and the Modified Four Square Step Test (mFSST). Each test will be performed twice, once with the shoulder sling and once without, in randomized order. The study aims to determine whether the sling provides measurable benefits in stability and performance during movement tasks. Data will be collected in rehabilitation centers under the supervision of clinical researchers.

Interventions

  • Device Shoulder Sling
    Use of a shoulder sling (Reh4mat AM-SOB) on the affected upper limb during mobility and balance testing.
  • Other No Sling
    Functional mobility tests performed without the use of any assistive shoulder device.

Primary outcome measures

  • Timed Up and Go (TUG) Test [Time frame: Within 1 day (each participant performs it twice - with and without sling)]
  • Functional Reach Test (FRT) [Time frame: Within 1 day (each participant performs it twice - with and without sling)]
  • Modified Four Square Step Test (mFSST) [Time frame: Within 1 day (each participant performs it twice - with and without sling)]

Eligibility criteria

Inclusion criteria

  • Clinical diagnosis of stroke in the subacute phase (up to 6 months post-onset)
  • Hemiplegia affecting one upper limb
  • Brunnstrom stage < 4 for the affected upper limb
  • Functional Ambulation Category (FAC) score > 3
  • Age between 40 and 80 years
  • Ability to follow simple instructions
  • Medically stable to participate in balance and mobility testing
  • Signed informed consent

Exclusion criteria

  • Severe cognitive impairment (e.g. MMSE < 23)
  • Visual or vestibular disorders affecting balance
  • Significant orthopedic or musculoskeletal conditions of the lower limbs
  • Uncontrolled cardiovascular or pulmonary disease
  • Use of assistive devices that prevent sling application
  • Severe aphasia interfering with understanding or communication
  • Skin lesions or injuries at the shoulder region preventing sling use

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Supportive care

Study locations

Greece · 1 center
  • Filoktitis Recovery and Rehabilitation Center — Koropí

Identifiers

NCT: NCT06904768 · SLS2025-GR01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗